PMID- 17596666 OWN - NLM STAT- MEDLINE DCOM- 20070809 LR - 20181113 IS - 1011-8934 (Print) IS - 1598-6357 (Electronic) IS - 1011-8934 (Linking) VI - 22 IP - 3 DP - 2007 Jun TI - RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. PG - 529-35 AB - Recovery from hepatitis B virus (HBV) infection depends on the cellular immune responses. Chemokines and their receptors play significant roles in immune defense. This study was undertaken to investigate the association between HBV infection and single nucleotide polymorphisms (SNPs) of genes for the chemokines and their receptors. Between March 2002 and February 2004, a total of 957 single ethnic Korean patients were enrolled into two different groups; "HBV clearance group" (n=350), who have recovered from HBV infection, and "HBV persistence group" (n=607), who were repeatedly HBsAg-positive. The HBV persistence group was subdivided into "inactive carrier" and "HBV progression group (chronic hepatitis and cirrhosis)". We assessed polymorphisms in regulated and normal T-cell expressed and secreted (RANTES) at position -403, monocyte chemoattractant protein-1 (MCP-1) at position -2518, CCR2 V64I, CCR5 -2459, CXCR1 S276T and CXCR4 I138I using single primer extension assay. Genotype distributions of the "HBV clearance versus persistence group" and "inactive carrier versus HBV progression group" were compared. On the basis of unconditional logistic regression analysis with adjustment for age and sex, no statistically significant association with susceptibility to persistent HBV infection was observed with RANTES -403, MCP-1 -2518, CCR2 V64I, CCR5 -2459, CXCR1 S276T, and CXCR4 I138I polymorphisms. In addition, no association of analyzed SNPs with HBV disease progression was found. FAU - Cheong, Jae Youn AU - Cheong JY AD - Department of Gastroenterology, Genomic Research Center for Gastroenterology, Ajou University School of Medicine, San-5 Wonchon-dong, Youngtong-gu, Suwon, Korea. FAU - Cho, Sung Won AU - Cho SW FAU - Choi, Jeong Young AU - Choi JY FAU - Lee, Jung A AU - Lee JA FAU - Kim, Min Ho AU - Kim MH FAU - Lee, Jong Eun AU - Lee JE FAU - Hahm, Ki Baik AU - Hahm KB FAU - Kim, Jin Hong AU - Kim JH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Korea (South) TA - J Korean Med Sci JT - Journal of Korean medical science JID - 8703518 RN - 0 (CCL2 protein, human) RN - 0 (CCR2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CCL5) RN - 0 (Receptors, CCR2) RN - 0 (Receptors, CCR5) RN - 0 (Receptors, CXCR4) RN - 0 (Receptors, Chemokine) RN - 0 (Receptors, Interleukin-8A) SB - IM MH - Chemokine CCL2/*genetics MH - Chemokine CCL5/*genetics MH - Disease Progression MH - Genotype MH - Hepatitis B/ethnology/*genetics/*therapy MH - Hepatitis B virus/metabolism MH - Humans MH - Korea MH - *Polymorphism, Genetic MH - Receptors, CCR2 MH - Receptors, CCR5/*genetics MH - Receptors, CXCR4/*genetics MH - Receptors, Chemokine/*genetics MH - Receptors, Interleukin-8A/*genetics MH - Regression Analysis MH - Treatment Outcome PMC - PMC2693650 EDAT- 2007/06/29 09:00 MHDA- 2007/08/10 09:00 PMCR- 2007/06/01 CRDT- 2007/06/29 09:00 PHST- 2007/06/29 09:00 [pubmed] PHST- 2007/08/10 09:00 [medline] PHST- 2007/06/29 09:00 [entrez] PHST- 2007/06/01 00:00 [pmc-release] AID - 200706529 [pii] AID - 10.3346/jkms.2007.22.3.529 [doi] PST - ppublish SO - J Korean Med Sci. 2007 Jun;22(3):529-35. doi: 10.3346/jkms.2007.22.3.529.